Biotie: Change in the number of votes


BIOTIE  THERAPIES CORP.                     Stock Exchange  Release            3
April 2014 at 2.45 pm

Biotie: Change in the number of votes

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares, that were issued on 2 January 2014, pursuant to the
Stock Option Plan 2011 and the Equity Incentive Plan 2011 as follows:

Shares conveyed Cumulative shares conveyed since Remaining shares to be conveyed
                         2 January 2014

    752,500                1,091,250                        2,230,410




Under the Stock Option Plan 2011, the owners of the stock options may subscribe
for a maximum total of 7,401,000 new shares in the Company or existing shares
held by the Company. A total of 427,500 shares have been subscribed for during
the period 28 February 2014 and 3 April 2014 and 427,500 of the treasury shares
will be used for these share subscriptions. The subscription price of EUR 0.01
per share has been fully paid by the employee and the EUR 4,275 funds received
will be credited to the Company's reserve for non-restricted equity.

The first vesting period of the Equity Incentive Plan 2011 ended on 5 January
2014, after which the Company's shares shall be delivered to employees on the
basis of the granted share units. It was resolved pursuant to the authorization
of the Annual General Meeting of the Shareholders to issue 325,000 existing
treasury shares to the employees without consideration for the purposes of
remunerating the employees pursuant to the terms and conditions of the Equity
Incentive Plan 2011 and thus, there is an especially weighty financial reason to
derogate from the pre-emptive right of the shareholders, as referred to in
Chapter 9 Section 4(1) of the Companies Act (624/2006, as amended).

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:

   Increase in number of     Total amount of     Number of the     Total number
     outstanding shares       voting rights  Company's shares held of registered
                                                 by the Group         shares

          752,500              447,305,198         8,727,200        456,032,398




Turku, 3 April 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

www.biotie.com
DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media


[HUG#1774201]